title: Diabetes depresses synaptic transmission in sympathetic ganglia by inactivating nAChRs through a conserved intracellular cysteine residue.
abstract: Most people with diabetes develop severe complications of the autonomic nervous system; yet, the underlying causes of many diabetic-induced dysautonomias are poorly understood. Here we explore the idea that these dysautonomias results, in part, from a defect in synaptic transmission. To test this idea, we investigated cultured sympathetic neurons and show that hyperglycemia inactivates nAChRs through a mechanism involving an elevation in reactive oxygen species and an interaction with highly conserved cysteine residues located near the intracellular mouth of the nAChR channel. Consistent with this, we show that diabetic mice have depressed ganglionic transmission and reduced sympathetic reflexes, whereas diabetic mice expressing mutant postsynaptic nAChRs that lack the conserved cysteine residues on the alpha3 subunit have normal synaptic transmission in sympathetic ganglia and normal sympathetic reflexes. Our work suggests a new model for diabetic-induced dysautonomias and identifies ganglionic nAChRs as targets of hyperglycemia-induced downstream signals.
authors.affiliation: Department of Physiology, McGill University, Montreal, Quebec H3G 1Y6, Canada.
authors.forename: Verónica
authors.initials: V
authors.lastname: Campanucci
authors.forename: Arjun
authors.initials: A
authors.lastname: Krishnaswamy
authors.forename: Ellis
authors.initials: E
authors.lastname: Cooper
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology; D000256:Adenoviridae; D000367:Age Factors; D000447:Aldehydes / Q000378:metabolism; D000818:Animals; D000831:Animals, Newborn; D001831:Body Temperature / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured; D003545:Cysteine / Q000235:genetics / Q000378:metabolism*; D003921:Diabetes Mellitus, Experimental / Q000139:chemically induced / Q000473:pathology*; D004195:Disease Models, Animal; D004791:Enzyme Inhibitors / Q000494:pharmacology; D019706:Excitatory Postsynaptic Potentials / Q000187:drug effects / Q000235:genetics; D005947:Glucose / Q000494:pharmacology; D006146:Guanidines / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology; D007004:Hypoglycemic Agents / Q000494:pharmacology; D007328:Insulin / Q000494:pharmacology; D020738:Leptin / Q000235:genetics; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D009154:Mutation / Q000235:genetics; D018384:Oxidative Stress / Q000187:drug effects / Q000502:physiology; D018408:Patch-Clamp Techniques; D017382:Reactive Oxygen Species / Q000378:metabolism; D054411:Receptors, Leptin / Q000235:genetics; D011978:Receptors, Nicotinic / Q000172:deficiency / Q000378:metabolism*; D011984:Sensory Receptor Cells / Q000502:physiology*; D017783:Superior Cervical Ganglion / Q000473:pathology*; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology*
chemical_list: D000109:Acetylcholine; D000447:Aldehydes; D003545:Cysteine; D004791:Enzyme Inhibitors; D005947:Glucose; D006146:Guanidines; D007004:Hypoglycemic Agents; D007328:Insulin; D020738:Leptin; D017382:Reactive Oxygen Species; D054411:Receptors, Leptin; D011978:Receptors, Nicotinic; C027576:4-hydroxy-2-nonenal; C004479:pimagedine